{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:28:01Z","timestamp":1789079281194,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Improving regeneration of damaged thymus is important for reconstituting T-cell immunity. Interleukin-22 (IL-22) was proved to improve thymus regeneration through recovering thymic epithelial cells (TECs). The IL-22 receptor IL-22RA1 is crucial for mediating IL-22 functions. Mechanism that regulates IL-22RA1 expression is unknown. Through using TECs-conditional knockout mice, we found aryl hydrocarbon receptor (AHR) is important for thymus regeneration, because Foxn1-cre-mediated AHR knockout (<jats:italic>Ahr<\/jats:italic>KO) significantly blocks recovery of thymus cells. Giving mice the AHR inhibitor CH-223191 or the AHR agonist FICZ blocks or accelerates thymus regeneration, respectively. <jats:italic>Ahr<\/jats:italic>KO-mediated blockade of thymus regeneration could not be rescued by giving exogenous IL-22. Mechanistically, <jats:italic>Ahr<\/jats:italic>KO mice shows decreased IL-22RA1 expression. In the murine TECs cell line mTEC1 cells, targeting AHR shows an impact on IL-22RA1 mRNA levels. Using chromatin immunoprecipitation and luciferase reporter assays, we find AHR co-operates with STAT3, binds the promotor region of IL-22RA1 gene and transcriptionally increases IL-22RA1 expression in mTEC1 cells. Foxn1-cre-mediated IL-22RA1 knockout (<jats:italic>Il22ra1<\/jats:italic>KO) blocks thymus regeneration after irradiation. Furthermore, targeting AHR or IL-22RA1 has significant impacts on severity of murine chronic graft-versus-host disease (cGVHD), which is an autoimmune-like complication following allogeneic hematopoietic cell transplantation. Giving FICZ decreases cGVHD, whereas <jats:italic>Il22ra1<\/jats:italic>KO exacerbates cGVHD. The impacts on cGVHD are associated with thymus regeneration and T-cell immune reconstitution. In conclusion, we report an unrecognized function of TECs-expressed AHR in thymus regeneration and AHR transcriptionally regulates IL-22RA1 expression, which have implications for improving thymus regeneration and controlling cGVHD.<\/jats:p>","DOI":"10.1038\/s41536-023-00339-7","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T10:02:33Z","timestamp":1699437753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Aryl hydrocarbon receptor regulates IL-22 receptor expression on thymic epithelial cell and accelerates thymus regeneration"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2387-8484","authenticated-orcid":false,"given":"Jingyi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2004-2595","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1667-2688","authenticated-orcid":false,"given":"Fei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5443-655X","authenticated-orcid":false,"given":"Shuo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6289-4934","authenticated-orcid":false,"given":"Qiu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6023-1770","authenticated-orcid":false,"given":"Kailin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2697-8985","authenticated-orcid":false,"given":"Bin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"339_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nri2669","volume":"9","author":"L Klein","year":"2009","unstructured":"Klein, L., Hinterberger, M., Wirnsberger, G. & Kyewski, B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat. Rev. Immunol. 9, 833\u2013844 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"339_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12418","volume":"271","author":"MS Chaudhry","year":"2016","unstructured":"Chaudhry, M. S., Velardi, E., Dudakov, J. A. & van den Brink, M. R. Thymus: the next (re)generation. Immunol. Rev. 271, 56\u201371 (2016).","journal-title":"Immunol. Rev."},{"key":"339_CR3","doi-asserted-by":"publisher","first-page":"706244","DOI":"10.3389\/fimmu.2021.706244","volume":"12","author":"M Duah","year":"2021","unstructured":"Duah, M. et al. Thymus Degeneration and Regeneration. Front. Immunol. 12, 706244 (2021).","journal-title":"Front. Immunol."},{"key":"339_CR4","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1182\/blood-2016-06-724005","volume":"128","author":"C de Koning","year":"2016","unstructured":"de Koning, C., Nierkens, S. & Boelens, J. J. Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution. Blood. 128, 2607\u20132615 (2016).","journal-title":"Blood."},{"key":"339_CR5","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1182\/blood-2011-02-334623","volume":"117","author":"W Krenger","year":"2011","unstructured":"Krenger, W., Blazar, B. R. & Hollander, G. A. Thymic T-cell development in allogeneic stem cell transplantation. Blood. 117, 6768\u20136776 (2011).","journal-title":"Blood."},{"key":"339_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-immunol-051116-052320","volume":"35","author":"J Abramson","year":"2017","unstructured":"Abramson, J. & Anderson, G. Thymic Epithelial Cells. Annu. Rev. Immunol. 35, 85\u2013118 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"339_CR7","doi-asserted-by":"publisher","first-page":"e20211239","DOI":"10.1084\/jem.20211239","volume":"219","author":"AS Alawam","year":"2022","unstructured":"Alawam, A. S. et al. Failures in thymus medulla regeneration during immune recovery cause tolerance loss and prime recipients for auto-GVHD. J. Exp. Med. 219, e20211239 (2022).","journal-title":"J. Exp. Med."},{"key":"339_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1218004","volume":"336","author":"JA Dudakov","year":"2012","unstructured":"Dudakov, J. A. et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science. 336, 91\u201395 (2012).","journal-title":"Science."},{"key":"339_CR9","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.bbmt.2019.06.002","volume":"25","author":"B Pan","year":"2019","unstructured":"Pan, B. et al. IL-22 Accelerates Thymus Regeneration via Stat3\/Mcl-1 and Decreases Chronic Graft-versus-Host Disease in Mice after Allotransplants. Biol. Blood Marrow Transplant. 25, 1911\u20131919 (2019).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"339_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","volume":"33","author":"JA Dudakov","year":"2015","unstructured":"Dudakov, J. A., Hanash, A. M. & van den Brink, M. R. Interleukin-22: immunobiology and pathology. Annu. Rev. Immunol. 33, 747\u2013785 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"339_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","volume":"48","author":"C Gutierrez-Vazquez","year":"2018","unstructured":"Gutierrez-Vazquez, C. & Quintana, F. J. Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity. 48, 19\u201333 (2018).","journal-title":"Immunity."},{"key":"339_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.intimp.2018.12.023","volume":"67","author":"B Pan","year":"2019","unstructured":"Pan, B. et al. Donor T-cell-derived interleukin-22 promotes thymus regeneration and alleviates chronic graft-versus-host disease in murine allogeneic hematopoietic cell transplant. Int. Immunopharmacol. 67, 194\u2013201 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"339_CR13","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1056\/NEJMra1703472","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser, R. & Blazar, B. R. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets. N. Engl. J. Med. 377, 2565\u20132579 (2017).","journal-title":"N. Engl. J. Med."},{"key":"339_CR14","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1158\/0008-5472.CAN-17-3131","volume":"78","author":"W He","year":"2018","unstructured":"He, W. et al. IL22RA1\/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer. Cancer Res. 78, 3293\u20133305 (2018).","journal-title":"Cancer Res."},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"103049","DOI":"10.1016\/j.jaut.2023.103049","volume":"138","author":"W Huang","year":"2023","unstructured":"Huang, W. et al. The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis. J Autoimmun. 138, 103049 (2023).","journal-title":"J Autoimmun."},{"key":"339_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/mi.2016.133","volume":"10","author":"JM Lanis","year":"2017","unstructured":"Lanis, J. M. et al. Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia. Mucosal Immunol. 10, 1133\u20131144 (2017).","journal-title":"Mucosal Immunol."},{"key":"339_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00008571-200203000-00009","volume":"12","author":"RS Thomas","year":"2002","unstructured":"Thomas, R. S. et al. Sequence variation and phylogenetic history of the mouse Ahr gene. Pharmacogenetics. 12, 151\u2013163 (2002).","journal-title":"Pharmacogenetics."},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood-2014-08-597245","volume":"125","author":"S Dertschnig","year":"2015","unstructured":"Dertschnig, S. et al. Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD. Blood. 125, 2720\u20132723 (2015).","journal-title":"Blood."},{"key":"339_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4049\/jimmunol.1300657","volume":"191","author":"T Wu","year":"2013","unstructured":"Wu, T. et al. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells. J. Immunol. 191, 488\u2013499 (2013).","journal-title":"J. Immunol."},{"key":"339_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3324\/haematol.2010.029702","volume":"96","author":"E Castermans","year":"2011","unstructured":"Castermans, E. et al. Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. Haematologica. 96, 298\u2013306 (2011).","journal-title":"Haematologica."},{"key":"339_CR21","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser, R. & Blazar, B. R. Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N. Engl. J. Med. 377, 2167\u20132179 (2017).","journal-title":"N. Engl. J. Med."},{"key":"339_CR22","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.celrep.2016.09.082","volume":"17","author":"JA Goettel","year":"2016","unstructured":"Goettel, J. A. et al. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice. Cell Rep. 17, 1318\u20131329 (2016).","journal-title":"Cell Rep."},{"key":"339_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12016-020-08789-3","volume":"59","author":"L Pernomian","year":"2020","unstructured":"Pernomian, L., Duarte-Silva, M. & de Barros Cardoso, C. R. The Aryl Hydrocarbon Receptor (AHR) as a Potential Target for the Control of Intestinal Inflammation: Insights from an Immune and Bacteria Sensor Receptor. Clin. Rev. Allergy Immunol. 59, 382\u2013390 (2020).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"339_CR24","doi-asserted-by":"publisher","first-page":"20768","DOI":"10.1073\/pnas.1009201107","volume":"107","author":"FJ Quintana","year":"2010","unstructured":"Quintana, F. J. et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 107, 20768\u201320773 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"339_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","volume":"37","author":"AM Hanash","year":"2012","unstructured":"Hanash, A. M. et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity. 37, 339\u2013350 (2012).","journal-title":"Immunity."},{"key":"339_CR26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1182\/blood.2021015111","volume":"141","author":"DM Ponce","year":"2023","unstructured":"Ponce, D. M. et al. A phase 2 study of Interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract. Blood. 141, 1389\u20131401 (2023).","journal-title":"Blood."},{"key":"339_CR27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1182\/blood-2017-01-762658","volume":"130","author":"JA Dudakov","year":"2017","unstructured":"Dudakov, J. A. et al. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease. Blood. 130, 933\u2013942 (2017).","journal-title":"Blood."},{"key":"339_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/toxsci\/kfx215","volume":"161","author":"AK Ehrlich","year":"2018","unstructured":"Ehrlich, A. K. et al. TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4(+) T Cell Differentiation. Toxicol. Sci. 161, 310\u2013320 (2018).","journal-title":"Toxicol. Sci."},{"key":"339_CR29","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.4049\/jimmunol.1501727","volume":"196","author":"NP Singh","year":"2016","unstructured":"Singh, N. P. et al. Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA. J. Immunol. 196, 1108\u20131122 (2016).","journal-title":"J. Immunol."},{"key":"339_CR30","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/ijms20112652","volume":"20","author":"Y Ishihara","year":"2019","unstructured":"Ishihara, Y. et al. Role of NF-kB RelB in Aryl Hydrocarbon Receptor-Mediated Ligand Specific Effects. Int. Mol. Sci. 20, 2652 (2019).","journal-title":"Int. Mol. Sci."},{"key":"339_CR31","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.4049\/jimmunol.171.8.4113","volume":"171","author":"S Tomita","year":"2003","unstructured":"Tomita, S. et al. T cell-specific disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution. J. Immunol. 171, 4113\u20134120 (2003).","journal-title":"J. Immunol."},{"key":"339_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00204-018-2366-x","volume":"93","author":"CA Beamer","year":"2019","unstructured":"Beamer, C. A., Kreitinger, J. M., Cole, S. L. & Shepherd, D. M. Targeted deletion of the aryl hydrocarbon receptor in dendritic cells prevents thymic atrophy in response to dioxin. Arch. Toxicol. 93, 355\u2013368 (2019).","journal-title":"Arch. Toxicol."},{"key":"339_CR33","doi-asserted-by":"publisher","first-page":"eabn8144","DOI":"10.1126\/sciimmunol.abn8144","volume":"7","author":"N Kadouri","year":"2022","unstructured":"Kadouri, N. et al. Transcriptional regulation of the thymus master regulator Foxn1. Sci. Immunol. 7, eabn8144 (2022).","journal-title":"Sci. Immunol."},{"key":"339_CR34","doi-asserted-by":"publisher","first-page":"e22436","DOI":"10.1096\/fj.202200249RR","volume":"36","author":"S Machcinska","year":"2022","unstructured":"Machcinska, S. et al. Hypoxia reveals a new function of Foxn1 in the keratinocyte antioxidant defense system. Faseb J. 36, e22436 (2022).","journal-title":"Faseb J."},{"key":"339_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","volume":"66","author":"JJ O\u2019Shea","year":"2015","unstructured":"O\u2019Shea, J. J. et al. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu. Rev. Med. 66, 311\u2013328 (2015).","journal-title":"Annu. Rev. Med."},{"key":"339_CR36","doi-asserted-by":"publisher","first-page":"764","DOI":"10.4049\/jimmunol.0903006","volume":"184","author":"V Radojcic","year":"2010","unstructured":"Radojcic, V. et al. STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model. J Immunol. 184, 764\u2013774 (2010).","journal-title":"J Immunol."},{"key":"339_CR37","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","volume":"127","author":"R Flynn","year":"2016","unstructured":"Flynn, R. et al. Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. Blood. 127, 2144\u20132154 (2016).","journal-title":"Blood."},{"key":"339_CR38","doi-asserted-by":"publisher","first-page":"e2203894119","DOI":"10.1073\/pnas.2203894119","volume":"119","author":"W Chen","year":"2022","unstructured":"Chen, W. et al. Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2. Proc. Natl. Acad. Sci. USA. 119, e2203894119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"339_CR39","doi-asserted-by":"publisher","first-page":"113712","DOI":"10.1016\/j.bcp.2019.113712","volume":"171","author":"L Li","year":"2020","unstructured":"Li, L. et al. Janus kinase inhibitor ruxolitinib blocks thymic regeneration after acute thymus injury. Biochem. Pharmacol. 171, 113712 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"339_CR40","doi-asserted-by":"publisher","first-page":"134.e1","DOI":"10.1016\/j.jtct.2021.12.001","volume":"28","author":"J Gao","year":"2022","unstructured":"Gao, J. et al. Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect. Transplant Cell Ther. 28, 134.e1\u2013134.e10 (2022).","journal-title":"Transplant Cell Ther."},{"key":"339_CR41","doi-asserted-by":"publisher","first-page":"109051","DOI":"10.1016\/j.intimp.2022.109051","volume":"110","author":"Y Liang","year":"2022","unstructured":"Liang, Y. et al. Blockade of PD-1\/PD-L1 increases effector T cells and aggravates murine chronic graft-versus-host disease. Int Immunopharmacol. 110, 109051 (2022).","journal-title":"Int Immunopharmacol."},{"key":"339_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft, T., Simpson, J. M. & Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 41, 467\u2013470 (1988).","journal-title":"J Clin Pathol."}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-023-00339-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-023-00339-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-023-00339-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T11:08:29Z","timestamp":1699441709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-023-00339-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1038\/s41536-023-00339-7","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}